insights_auto
Why is TWST up 4,51%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
149,13 US$
arrow_upward
+4,51%(+6,43) 1D
149,15 US$
arrow_upward
+0,01% (+0,022)bedtimeAfter hours
Closed: 21 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
139,34 US$
High
153,80 US$
Low
138,25 US$
Mkt. cap
9,88 მლრდ.
Avg. vol.
2,84 მლნ.
Volume
2,64 მლნ.
52-wk high
219,71 US$
52-wk low
23,30 US$
EPS
-2,22 US$
Beta
2,19
Shares outstanding
65,83 მლნ.
No. of employees
979
Open
139,34 US$
High
153,80 US$
Low
138,25 US$
Mkt. cap
9,88 მლრდ.
Avg. vol.
2,84 მლნ.
Volume
2,64 მლნ.
52-wk high
219,71 US$
52-wk low
23,30 US$
EPS
-2,22 US$
Beta
2,19
Shares outstanding
65,83 მლნ.
No. of employees
979
News stories
From web sources and news partners
Yahoo Finance
·
33 წუთის წინ
Direct Digital Holdings Announces Intention to Voluntarily Delist from Nasdaq and Deregister Its Class A Common Stock with the SEC
MarketBeat
·
8 წუთის წინ
Meta Platforms (NASDAQ:META) COO Sells $669,011.20 in Stock
TradingView
·
19 წუთის წინ
S&P 500, Nasdaq Gain, Powered By Meta, Tesla Stock — SPCX, META, TSLA, SKYD, IBM In Focus
Reuters
·
16 წუთის წინ
Nasdaq leads Wall Street gains as SpaceX, Super Micro aid AI sentiment
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp